超越耐药性：评估舒巴坦-杜鲁巴坦在当今临床中的作用

IF 4.2 2区医学 Q1 INFECTIOUS DISEASES

Expert Review of Anti-infective Therapy Pub Date : 2024-05-02 DOI:10.1080/14787210.2024.2351026

Ahmad Z. Al Meslamani

引用次数: 0

摘要

发表于《抗感染治疗专家评论》（刚被接受，2024 年）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Beyond resistance: assessing sulbactam-Durlobactam’s role in Today’s clinical landscape

Published in Expert Review of Anti-infective Therapy (Just accepted, 2024)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Expert Review of Anti-infective Therapy 医学-药学

CiteScore

11.20

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Expert Review of Anti-Infective Therapy (ISSN 1478-7210) provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.